MeSH D004892 - erythema multiforme
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| A.H. Robins Company | Methylprednisolone | Methylprednisolone |  | 1982-01-01 |  |  |
| Prednisolone | Prednisolone |  | 1982-01-01 |  |  | |
| Prednisone | Prednisone |  | 1982-01-01 |  |  | |
| Abbott Biotherapeutics | Methylprednisolone | A-methapred |  | 1991-02-22 |  |  |
| AbbVie | Prednisolone | Pred |  | 1982-01-01 |  |  |
| Prednisolone | Pred Mild |  | 1982-01-01 |  |  | |
| Alcon Research | Prednisolone, Sulfacetamide | Cetapred |  | 1993-08-06 |  |  |
| Prednisolone, Sulfacetamide | Isopto Cetapred |  | 1982-01-01 |  |  | |
| Prednisolone | Prednisolone |  | 1991-10-24 |  |  | |
| Allergan | Prednisolone, Sulfacetamide | Blephamide |  | 1986-12-03 |  |  |
| Prednisolone, Chloramphenicol | Chloroptic-p |  | 1982-01-01 |  |  | |
| Prednisolone, Neomycin, Polymyxin b | Poly-pred |  | 1982-01-01 |  |  | |
| Prednisolone, Gentamicin | Pred |  | 1988-06-10 |  |  | |
| Methylprednisolone | Methylprednisolone |  | 1997-10-16 |  |  | |
| Prednisolone | Prednisolone |  | 1982-01-01 |  |  | |
| Prednisolone tebutate | Prednisolone Tebutate |  | 1984-02-17 |  |  | |
| Prednisone | Prednisone |  | 1982-01-01 |  |  | |
| American Therapeutics | Prednisone | Prednisone |  | 1986-11-06 |  |  |
| Amneal Pharmaceuticals | Methylprednisolone | Methylprednisolone |  | 2021-09-21 |  |  |
| Prednisolone | Prednisolone |  | 2009-03-10 |  |  | |
| Prednisone | Prednisone |  | 1987-10-05 |  |  |
1
2
3
4
5
6
...
12
>
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
0%0/0
Phase 3
100%8/8
Approved: 8Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
...
8
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use